These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2725937)

  • 61. [Successful treatment for intractable ascites with uterine cancer using double Denver peritoneovenous shunt system].
    Kawamoto J; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1919-23. PubMed ID: 17212147
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peritoneovenous shunt - modification with the use of long saphenous vein.
    Utíkal P; Drác P; Bachleda P; Klein J; Král V; Hrabalová M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):89-90. PubMed ID: 15523554
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Denver peritoneovenous shunt in the management of refractory ascites due to chronic liver diseases: impact of patients selection on its outcome.
    Abbas M; El Damarawy M; Seyam M; Awad A; Madkour ME; Salah M
    J Egypt Soc Parasitol; 2007 Dec; 37(3 Suppl):1159-74. PubMed ID: 18431991
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Surgical treatment of intractable ascites].
    Kvist N; Friis J; Nielsen OV
    Ugeskr Laeger; 1983 Sep; 145(38):2926-9. PubMed ID: 6649100
    [No Abstract]   [Full Text] [Related]  

  • 65. [Sapheno-peritoneal shunt for the treatment of ascites].
    Nagy Z; Gyurkovics E; Kaliszky P; Kupcsulik P
    Magy Seb; 2001 Aug; 54(4):235-8. PubMed ID: 11550492
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Umbilical hernioplasty with valve implantation in cirrhotic-ascitic patients].
    Vincze K; Csorba L
    Orv Hetil; 1991 Apr; 132(15):805-8. PubMed ID: 2041650
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Therapy of resistant ascites using the peritoneojugular (Leveen shunt)].
    Gavrilović S; Fabri M; Dzambas D; Majoros J; Gvozdenović L; Damjanov D
    Med Pregl; 1990; 43(5-6):260-4. PubMed ID: 2287315
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Peritoneal venous shunting for ascites: a 15-year perspective.
    Hyde GL; Dillon M; Bivins BA
    Am Surg; 1982 Mar; 48(3):123-7. PubMed ID: 7073133
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt.
    Gibson PR; Dudley FJ; Jakobovits AW; Salem HH; McInnes IE
    Aust N Z J Med; 1981 Feb; 11(1):8-12. PubMed ID: 6941784
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The continuous peritoneo-jugular shunt (Le Veen's valve) in the treatment of refractory ascites. Personal experience].
    Rocca F; Scorti A; Ratti G; D'Errico F; Lualdi M
    Recenti Prog Med; 1981 Oct; 71(4):420-36. PubMed ID: 7335948
    [No Abstract]   [Full Text] [Related]  

  • 72. [Experience with the transjugular intrahepatic portocaval shunt].
    Dagenais M; Pomier Layrargues G; Dufresne MP; Roy A; Fenyves D; Lapointe R
    Ann Chir; 1994; 48(8):671-8. PubMed ID: 7872613
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Peritoneo-venous shunt in the treatment of therapy-resistant ascites].
    Zühlke HV; Häring R; Semsch B
    Med Welt; 1981 Apr; 32(15):578-83. PubMed ID: 7231116
    [No Abstract]   [Full Text] [Related]  

  • 74. The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.
    Smadja C; Franco D
    Ann Surg; 1985 Apr; 201(4):488-93. PubMed ID: 3977450
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Surgical treatment of refractory ascites with peritoneovenous shunt and its complications].
    Brescia A; La Torre F; Pieralisi G
    Ann Ital Chir; 1983; 55(4):385-93. PubMed ID: 6673622
    [No Abstract]   [Full Text] [Related]  

  • 76. [Comparative evaluation of the effects of a peritoneo-venous shunt and of concentration-reinfusion on the survival of cirrhotic subjects with "intractable" ascites].
    Torre GC; Testa R
    Minerva Med; 1982 Jun; 73(27):1871-5. PubMed ID: 7088400
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Treatment of ascites resistent to medical therapy by using a peritoneovenous shunt: technic and the early results of our experience].
    Conti A; Lucisano E; Forghieri E
    Ann Ital Chir; 1979; 51(2):139-43. PubMed ID: 554488
    [No Abstract]   [Full Text] [Related]  

  • 78. LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized, prospective trial.
    Fulenwider JT; Galambos JD; Smith RB; Henderson JM; Warren WD
    Arch Surg; 1986 Mar; 121(3):351-5. PubMed ID: 3947233
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bizarre complications of peritoneovenous shunts.
    Eckhauser FE; Strodel WE; Girardy JW; Turcotte JG
    Ann Surg; 1981 Feb; 193(2):180-4. PubMed ID: 7469552
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Irreducible ascites in cirrhotic patients. Results of peritoneo-jugular shunt in 16 patients (author's transl)].
    Paliard P; Partensky C; Saubier E
    Nouv Presse Med; 1981 Sep; 10(33):2715-8. PubMed ID: 6974851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.